The guidance describes the information you should document at the manufacturing facility and include in any premarket submissions. It is intended to help medical device manufacturers identify the possible risks related to tissues from animal sources when these tissues are used in medical devices.
More Articles on Supply Chain:
Medline Launches New Products Catalog
Boston Scientific Looks to Expand Chinese Presence
Supply Chain Efficiency Improved With Inventory Management Intervention
